Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline

Encoded Therapeutics Raises $275 Million in Series F Financing to Advance Precision Genetic Medicines Neurology Pipeline ...
Yahoo Finance

A Must-Read True Crime Novel in 2022: Encoded by R.W. Gates

New York, New York--(Newsfile Corp. - May 10, 2022) - Thriller author R.W. Gates keeps audiences spellbound with his latest true-crime novel, Encoded. This haunting tale is based on actual events and ...
irblog.prnewswire.com

Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for ...

SOUTH SAN FRANCISCO, Calif., July 22, 2020 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company, today announced it has raised $135 million in an oversubscribed ...
Pulse 2.0

Encoded Therapeutics Closes $135 Million In Series D Funding

Precision gene therapy company Encoded Therapeutics announced it has raised $135 million in an oversubscribed Series D round of funding Precision gene therapy company Encoded Therapeutics, Inc.
Morningstar%2c Inc.

Encoded Therapeutics Presents New Preclinical Data at ASGCT 2026 Highlighting Precision Vector Engineering Across Neurology Programs

– NociPro enables highly selective nociceptor targeting and potent NaV1.7 knockdown in rodents and non-human primates, supporting development candidate ETX301 for post‑amputation neuroma pain – – ...
Morningstar%2c Inc.

Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the 16th European Epilepsy Congress

Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that new Phase 1/2 POLARIS data ...
Business Wire

Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, ...
Business Wire

Encoded Therapeutics Strengthens Clinical Leadership Team with Appointment of Professor Joseph Sullivan, M.D., as Vice President of Clinical Development

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc. (“Encoded”), a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today ...
Pulse 2.0

Encoded Ventures Launched To Back Early-Stage Infrastructure Innovation

Encoded Ventures, a new early-stage venture capital firm founded by longtime investor Alex Benik, has officially launched, marking a renewed focus on innovation across cloud, data, and cybersecurity ...